How Effective are PD-L1 Inhibitors in Cancer Treatment?
The effectiveness of PD-L1 inhibitors can vary depending on the type of cancer and the individual patient. Clinical trials have demonstrated significant improvements in overall survival and progression-free survival for patients treated with these inhibitors. However, not all patients respond to PD-L1 inhibitors, and biomarkers such as PD-L1 expression levels are often used to identify those who are most likely to benefit.
